Abstract
Coronavirus disease 2019 is caused by SARS-CoV-2 and is more severe in the elderly, racial minorities, and those with comorbidities such as hypertension and diabetes. These pathologies are often controlled with medications involving the renin–angiotensin–aldosterone system (RAAS). RAAS is an endocrine system involved in maintaining blood pressure and blood volume through components of the system. SARS-CoV-2 enters the cells through ACE2, a membrane-bound protein related to RAAS. Therefore, the use of RAAS inhibitors could worsen the severity of COVID-19’s symptoms, especially amongst those with pre-existing comorbidities. Although a vaccine is currently available to prevent and reduce the symptom severity of COVID-19, other options, such as nitric oxide and hydrogen sulfide, may also have utility to prevent and treat this virus.
Funder
National Institutes of Health
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference189 articles.
1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Lancet,2020
2. Return-to-work, disabilities and occupational health in the age of COVID-19;Scand. J. Work Environ. Health,2021
3. CDC (2022, August 17). About COVID-19: People with Certain Medical Conditions, Available online: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html.
4. Aging and COVID-19 in Minority Populations: A Perfect Storm;Curr. Epidemiol. Rep.,2021
5. The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States;Clin. Infect. Dis.,2021
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献